Valnoctamide (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Valnoctamide" in French language version.

refsWebsite
Global rank French rank
4th place
12th place
2nd place
3rd place
11th place
325th place
1,735th place
168th place
5,225th place
6,624th place
234th place
147th place
57th place
4th place

clinicaltrials.gov (Global: 5,225th place; French: 6,624th place)

  • RH Belmaker, Yuly Bersudsky, Alex Mishory et Beersheva Mental Health Center, « Valnoctamide in Mania », ClinicalTrials.gov, United States National Institutes of Health, (consulté le )

doi.org (Global: 2nd place; French: 3rd place)

dx.doi.org

  • Haj-Yehia et Meir Bialer, « Structure-pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity », Pharmaceutical Research, vol. 6, no 8,‎ , p. 683–689 (PMID 2510141, DOI 10.1023/A:1015934321764, S2CID 21531402)
  • Lindekens, Ilse Smolders, Ghous M. Khan et Meir Bialer, « In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy », Pharmaceutical Research, vol. 17, no 11,‎ , p. 1408–1413 (PMID 11205735, DOI 10.1023/A:1007559208599, S2CID 24229165)
  • Rogawski, « Diverse mechanisms of antiepileptic drugs in the development pipeline », Epilepsy Res, vol. 69, no 3,‎ , p. 273–294 (PMID 16621450, PMCID 1562526, DOI 10.1016/j.eplepsyres.2006.02.004)
  • Winkler, Simcha Blotnik, Jakob Shimshoni et Boris Yagen, « Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain », British Journal of Pharmacology, vol. 146, no 2,‎ , p. 198–208 (PMID 15997234, PMCID 1576263, DOI 10.1038/sj.bjp.0706310)
  • Pisani, Fazio, Artesi et Oteri, « Impairment of carbamazepine-10, 11-epoxide elimination by valnoctamide, a valpromide isomer, in healthy subjects », British Journal of Clinical Pharmacology, vol. 34, no 1,‎ , p. 85–87 (PMID 1352988, PMCID 1381382, DOI 10.1111/j.1365-2125.1992.tb04114.x)
  • Shimon Barel, Boris Yagen, Volker Schurig, Stephan Sobak, Francesco Pisani, Emilio Perucca and Meir Bialer, « Stereoselective pharmacokinetic analysis of valnoctamide in healthy subjects and in patients with epilepsy », Clinical Pharmacology & Therapeutics, vol. 61, no 4,‎ , p. 442–449 (PMID 9129561, DOI 10.1016/S0009-9236(97)90194-6, lire en ligne)
  • Isoherranen, H. Steve White, Brian D. Klein et Michael Roeder, « Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy », Pharmaceutical Research, vol. 20, no 8,‎ , p. 1293–1301 (PMID 12948028, DOI 10.1023/A:1025069519218, S2CID 20755032)
  • Freifelder, Geiszler et Stone, « Hydrolysis of 5,5-Disubstituted Barbituric Acids », The Journal of Organic Chemistry, vol. 26, no 1,‎ , p. 203–206 (ISSN 0022-3263, DOI 10.1021/jo01060a048)

issn.org (Global: 57th place; French: 4th place)

portal.issn.org

  • Freifelder, Geiszler et Stone, « Hydrolysis of 5,5-Disubstituted Barbituric Acids », The Journal of Organic Chemistry, vol. 26, no 1,‎ , p. 203–206 (ISSN 0022-3263, DOI 10.1021/jo01060a048)

nature.com (Global: 234th place; French: 147th place)

  • Shimon Barel, Boris Yagen, Volker Schurig, Stephan Sobak, Francesco Pisani, Emilio Perucca and Meir Bialer, « Stereoselective pharmacokinetic analysis of valnoctamide in healthy subjects and in patients with epilepsy », Clinical Pharmacology & Therapeutics, vol. 61, no 4,‎ , p. 442–449 (PMID 9129561, DOI 10.1016/S0009-9236(97)90194-6, lire en ligne)

nih.gov (Global: 4th place; French: 12th place)

ncbi.nlm.nih.gov

  • Harl, « [Clinical Study Of Valnoctamide On 70 Neuropsychiatric Clinic Patients Undergoing Ambulatory Treatment] », La Presse Médicale, vol. 72,‎ , p. 753–754 (PMID 14119722)
  • Haj-Yehia et Meir Bialer, « Structure-pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity », Pharmaceutical Research, vol. 6, no 8,‎ , p. 683–689 (PMID 2510141, DOI 10.1023/A:1015934321764, S2CID 21531402)
  • (pt) Mattos Nda, « [Use of Valnoctamide (nirvanil) in oligophrenic erethics and epileptics] », Hospital (Rio J), vol. 75, no 5,‎ , p. 1701–1704 (PMID 5306499)
  • Lindekens, Ilse Smolders, Ghous M. Khan et Meir Bialer, « In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy », Pharmaceutical Research, vol. 17, no 11,‎ , p. 1408–1413 (PMID 11205735, DOI 10.1023/A:1007559208599, S2CID 24229165)
  • Rogawski, « Diverse mechanisms of antiepileptic drugs in the development pipeline », Epilepsy Res, vol. 69, no 3,‎ , p. 273–294 (PMID 16621450, PMCID 1562526, DOI 10.1016/j.eplepsyres.2006.02.004)
  • Winkler, Simcha Blotnik, Jakob Shimshoni et Boris Yagen, « Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain », British Journal of Pharmacology, vol. 146, no 2,‎ , p. 198–208 (PMID 15997234, PMCID 1576263, DOI 10.1038/sj.bjp.0706310)
  • Pisani, Fazio, Artesi et Oteri, « Impairment of carbamazepine-10, 11-epoxide elimination by valnoctamide, a valpromide isomer, in healthy subjects », British Journal of Clinical Pharmacology, vol. 34, no 1,‎ , p. 85–87 (PMID 1352988, PMCID 1381382, DOI 10.1111/j.1365-2125.1992.tb04114.x)
  • Shimon Barel, Boris Yagen, Volker Schurig, Stephan Sobak, Francesco Pisani, Emilio Perucca and Meir Bialer, « Stereoselective pharmacokinetic analysis of valnoctamide in healthy subjects and in patients with epilepsy », Clinical Pharmacology & Therapeutics, vol. 61, no 4,‎ , p. 442–449 (PMID 9129561, DOI 10.1016/S0009-9236(97)90194-6, lire en ligne)
  • Isoherranen, H. Steve White, Brian D. Klein et Michael Roeder, « Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy », Pharmaceutical Research, vol. 20, no 8,‎ , p. 1293–1301 (PMID 12948028, DOI 10.1023/A:1025069519218, S2CID 20755032)

qmul.ac.uk (Global: 1,735th place; French: 168th place)

chem.qmul.ac.uk

semanticscholar.org (Global: 11th place; French: 325th place)

api.semanticscholar.org

  • Haj-Yehia et Meir Bialer, « Structure-pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity », Pharmaceutical Research, vol. 6, no 8,‎ , p. 683–689 (PMID 2510141, DOI 10.1023/A:1015934321764, S2CID 21531402)
  • Lindekens, Ilse Smolders, Ghous M. Khan et Meir Bialer, « In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy », Pharmaceutical Research, vol. 17, no 11,‎ , p. 1408–1413 (PMID 11205735, DOI 10.1023/A:1007559208599, S2CID 24229165)
  • Isoherranen, H. Steve White, Brian D. Klein et Michael Roeder, « Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy », Pharmaceutical Research, vol. 20, no 8,‎ , p. 1293–1301 (PMID 12948028, DOI 10.1023/A:1025069519218, S2CID 20755032)